Form D · Biotechnology
Gateway Biotechnology, Inc.
Durham, NC · CIK 0002071358
Offering snapshot reported Jun 5, 2025 · SEC filing
- Reported sold
- $633K Offering amount: $2.4M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 22, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 5, 2025 | Initial | $633,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-548202
Simple Agreement for Future Equity (SAFE) offering a 20% discount on future equity.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Folla Capital, LLC | 305140 | Folla Capital, LLC · CRD 305140 |
Source: Form D, filed Jun 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jianxin Bao | Executive |
| Richard Chole | Director |
| Philip Perez | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3805 Stoney Brook Drive
Durham, NC, 27705
Durham, NC, 27705